Apyx Medical
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $11,373 | $9,430 | $14,222 | $11,487 |
Gross Profit | 7,083 | 5,665 | 8,964 | 6,954 |
EBITDA | -2,574 | -3,051 | -2,775 | -3,089 |
EBIT | -3,189 | -2,917 | -3,233 | |
Net Income | -3,778 | -4,150 | -4,628 | -4,703 |
Net Change In Cash | 11,373 | 9,430 | 14,222 | 11,487 |
Free Cash Flow | -1,498 | -757 | -3,182 | -4,593 |
Cash | 29,301 | 31,011 | 31,741 | 28,013 |
Basic Shares | 40,729 | 35,542 | 38,215 | 34,644 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $48,102 | $52,349 | $44,510 | $48,517 |
Gross Profit | 29,360 | 33,759 | 29,131 | 33,601 |
EBITDA | -16,801 | -18,112 | -22,006 | -13,907 |
EBIT | -17,400 | -18,804 | -22,896 | -14,810 |
Net Income | -23,463 | -18,713 | -23,278 | -15,200 |
Net Change In Cash | 48,102 | 52,349 | 44,510 | 48,517 |
Cost of Revenue | -21,073 | -11,148 | ||
Free Cash Flow | -18,769 | -5,782 | -21,290 | -11,172 |
Cash | 31,741 | 43,652 | 10,192 | 30,870 |
Basic Shares | 35,542 | 34,622 | 34,516 | 34,332 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.09 |
2025-03-31 | -$0.10 |
2024-12-31 | -$0.12 |
